Drugs for Glioma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 462)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Trametinib |
Approved |
Phase 4 |
|
871700-17-3 |
11707110 |
Synonyms:
GSK 1120212
GSK1120212
GSK-1120212
GSK1120212|GSK1120212B|GSK212|JTP 74057|Mekinist®|trametinib dimethyl sulfoxide
GSK1120212B
GSK212
JTP 74057
|
JTP-74057
MEKINIST
TMT212
TRAMETINIB
TRAMÉTINIB
TRAMETINIB DIMETHYL SULFOXIDE
TRAMETINIBUM
|
|
2 |
|
Dabrafenib |
Approved, Investigational |
Phase 4 |
|
1195765-45-7 |
44462760 |
Synonyms:
DABRAFENIB
DRB436
GSK2118436
GSK-2118436
|
GSK2118436|GSK2118436A|Tafinlar®
GSK2118436a
GSK-2118436A
TAFINLAR
|
|
3 |
|
Lactitol |
Approved, Investigational |
Phase 4 |
|
585-86-4 |
157355 |
Synonyms:
4-O-beta-D-Galactopyranosyl-D-glucitol
4-O-β-D-Galactopyranosyl-D-glucitol
D-Lactitol
Emportal
Importal
Lactitol
|
Lactitolum
Neda lactiv importal
Oponaf
Pizensy
WURCS=2.0/2,2,1/[H2122H][a2112h-1b_1-5]/1-2/a4-b1
|
|
4 |
|
Temozolomide |
Approved, Investigational |
Phase 4 |
|
85622-93-1 |
5394 |
Synonyms:
3,4-Dihydro-3-methyl-4-oxoimidazo(5,1-D)-1,2,3,5-tetrazine-8-carboxamide
3,4-Dihydro-3-methyl-4-oxoimidazo(5,1-D)-as-tetrazine-8-carboxamide
3-Methyl-4-oxo-3,4-dihydroimidazo(5,1-D)(1,2,3,5)tetrazine-8-carboxamide
8-Carbamoyl-3-methylimidazo(5,1-D)-1,2,3,5-tetrazin-4(3H)-one
BRN 5547136
CCRG 81045
CCRG-81045
CCRIS 8996
m & b 39831
m And b 39831
m And b39831
m And b-39831
M&B 39831
M&B-39831
M-39831
MB 39831
Methazolastone
NSC 362856
NSC-362856
|
SCH 52365
SCH-52365
Temodal
Temodar
TEMOMEDAC
Temozolamide
Temozolodida
Temozolodida [Spanish]
Temozolomid
Temozolomida
Temozolomide
Témozolomide
Temozolomide hexyl ester
Temozolomidum
Temozolomidum [Latin]
TMZ
TMZ Bioshuttle
TMZA-he
TMZ-Bioshuttle
|
|
5 |
|
Alkylating Agents |
|
Phase 4 |
|
|
|
6 |
|
Antineoplastic Agents, Alkylating |
|
Phase 4 |
|
|
|
7 |
|
Prednisone |
Approved, Vet_approved |
Phase 3 |
|
53-03-2 |
5865 |
Synonyms:
1,2-Dehydrocortisone
1,4-Pregnadiene-17a,21-diol-3,11,20-trione
1,4-Pregnadiene-17alpha,21-diol-3,11,20-trione
1,4-Pregnadiene-17α,21-diol-3,11,20-trione
17,21-Dihydroxypregna-1,4-diene-3,11,20-trione
Acis brand OF prednisone
Acsis, prednison
Adasone
Ancortone
Apo-prednisone
Apotex brand OF prednisone
Aventis brand OF prednisone
Betapar
Bicortone
Cartancyl
Colisone
Cortan
Cortancyl
Cortidelt
Cotone
Cutason
Dacorten
Dacortin
Decortancyl
Decortin
Decortisyl
Dehydrocortisone
Dekortin
Delcortin
Dellacort
Dellacort A
Delta Cortelan
Delta E
Delta-cortelan
Deltacortene
delta-Cortisone
Deltacortisone
Deltacortone
Delta-cortone
DELTA-DOME
Deltasone
Deltison
Deltisona
Deltisone
Deltra
Diadreson
Di-Adreson
Diba brand OF prednisone
Econosone
Encorton
Encortone
Enkortolon
Enkorton
Fawns and mcallan brand OF prednisone
FERNISONE
Ferring brand OF prednisone
Fiasone
GALENpharma brand OF prednisone
Halsey drug brand OF prednisone
Hexal brand OF prednisone
Hoechst brand OF prednisone
Hostacortin
ICN brand OF prednisone
Incocortyl
In-Sone
Juvason
Kortancyl
Lichtenstein brand OF prednisone
|
Liquid pred
Lisacort
LODOTRA
Lodotra®|Sterapred®
Me-Korti
Merck brand OF prednisone
Merz brand OF prednisone
Metacortandracin
Meticorten
Mibe brand OF prednisone
Nisona
Nizon
Novoprednisone
NSC-10023
Nurison
Orasone
Origen Prednisone
Panafcort
Panasol
PARACORT
Parmenison
Pehacort
Pharmacia brand OF prednisone
PRD
Precort
Predeltin
PREDN
Predni tablinen
PREDNICEN-M
Prednicorm
Prednicort
Prednicot
Prednidib
Prednilonga
Predniment
Prednison
Prednison acsis
Prednison galen
Prednison hexal
Prednisona
Prednisona [INN-Spanish]
Prednisone
PREDNISONE INTENSOL
PREDNISONE TABLETS
Prednisonum
Prednisonum [INN-Latin]
Prednitone
Prednizon
Prednovister
Presone
Pronison
Pronisone
RAYOS
Rectodelt
Retrocortine
Schering-plough brand OF prednisone
Seatrace brand OF prednisone
SERVISONE
Solvay brand OF prednisone
Sone
Sterapred
Supercortil
Trommsdorff brand OF prednisone
Ultracorten
Ultracortene
Winpred
Wojtab
Zenadrid
|
|
8 |
|
Ifosfamide |
Approved |
Phase 3 |
|
3778-73-2 |
3690 |
Synonyms:
3-(2-Chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide
Asta Z 4942
Holoxan
Ifex
Ifosfamid
Ifosfamida
IFOSFAMIDE
Ifosfamide sterile
Ifosfamidum
Ifosphamide
Ifsofamide
Iphosphamid
|
Iphosphamide
I-phosphamide
Iso endoxan
Iso-endoxan
Isofosfamide
Isophosphamide
Isosfamide
MITOXANA
MJF-9325
NSC-109724
Z-4942
|
|
9 |
|
Dextroamphetamine |
Approved, Illicit, Investigational |
Phase 3 |
|
51-64-9, 300-62-9 |
5826 3007 |
Synonyms:
(±)-amphetamine|Amphetamine Sulfate®|DL-amphetamine
(+)-(S)-Amphetamine
(+)-alpha-Methylphenethylamine
(+)-alpha-Methylphenylethylamine
(+-)-alpha-Methylphenylethylamine
(+)-alpha-methylphenylethylamine|d-amphetamine|Dexadrine®|dextroamphetamine|Dextrostat®|S(+)amphetamine
(+)-a-Methylphenethylamine
(+)-a-Methylphenylethylamine
(+)-Amphetamine
(+)-phenaminum
(+)-Α-methylphenethylamine
(+)-Α-methylphenylethylamine
(+/-)-benzedrine
(+/-)-beta-phenylisopropylamine
(+/-)-desoxynorephedrine
(2S)-(+)-Amphetamine
(2S)-1-phenylpropan-2-amine
(AlphaS)-alpha-methylbenzeneethanamine
(AlphaS)-a-methylbenzeneethanamine
(AlphaS)-α-methylbenzeneethanamine
(S)-(+)-Amphetamine
(S)-(+)-beta-Phenylisopropylamine
(S)-(+)-b-Phenylisopropylamine
(S)-(+)-Î’-phenylisopropylamine
(S)-1-Phenyl-2-aminopropane
(S)-1-Phenyl-2-propanamine
(S)-1-Phenyl-2-propylamine
(S)-alpha-Methylbenzeneethanamine
(s)-alpha-methylphenethylamine
(s)-alpha-phenylethylamine
(S)-a-Methylbenzeneethanamine
(S)-Amphetamine
(S)-Α-methylbenzeneethanamine
(αS)-α-methylbenzeneethanamine
[1-(3-Methoxyphenyl)-2-propyl]amine
1-Methyl-2-phenylethylamine
1-Phenyl-2-aminopropane
3-Methoxy-a-methylbenzeneethanamine
3-Methoxyamphetamine
3-Methoxyphenylisopropylamine
Actedron
Adipan
Adzenys
ADZENYS ER
ADZENYS XR-ODT
Allodene
alpha-Methylbenzeneethaneamine
Amfetamin
Amfetamina
Amfetamine
Amfetaminum
Amphetamine
AMPHETAMINE RESIN COMPLEX
Amphetamine sulfate
Amphetamine sulfate (2:1)
Amsustain
Anorexide
Anorexine
Benzebar
Benzedrine
Benzolone
beta-Aminopropylbenzene
beta-Phenylisopropylamin
beta-Phenyl-isopropylamine
Celltech brand OF dextroamphetamine sulfate
Centramina
Curban
D Amphetamine
D Amphetamine sulfate
D-(+)-amphetamine
D-(s)-amphetamine
D-1-Phenyl-2-aminopropan
d-1-Phenyl-2-aminopropan [German]
D-1-Phenyl-2-aminopropane
D-2-Amino-1-phenylpropane
D-alpha-methylphenethylamine
D-am
D-Amphetamine
D-Amphetamine sulfate
Dephadren
Desamfetamina
Desoxyn
Desoxynorephedrin
Desoxynorephedrine
Dexacaps
Dexadrine
Dexamfetamina
|
Dexamfetamina [inn-spanish]
Dexamfetamine
Dexamfetaminum
Dexamfetaminum [inn-latin]
DEXAMPEX
Dexamphetamine
Dexamphetaminum [inn-latin]
Dexanfetamina
Dexanfetamina [inn-spanish]
Dexedrine
Dexedrine Spansule
Dexidrine
Dextro amphetamine
Dextro amphetamine sulfate
Dextroamphetamine
Dextro-amphetamine
DEXTROAMPHETAMINE RESIN COMPLEX
Dextroamphetamine sulfate
Dextro-amphetamine sulfate
DextroStat
DL-1-Phenyl-2-aminopropane
DL-alpha-Methylphenethylamine
DL-Amphetamine
DL-Benzedrine
Dyanavel
DYANAVEL XR
Elastonon
Fenamin
Fenamine
Fenylo-izopropylaminyl
FERNDEX
Finam
GlaxoSmithKline brand OF dextroamphetamine sulfate
Isoamycin
Isoamyne
Isomyn
L Amphetamine
L-Amphetamine
Levo amphetamine
Levoamphetamine
Levo-amphetamine
Mallinckrodt brand OF dextroamphetamine sulfate
Mecodrin
Methampex
Methamphetamine HCL
Miquel brand OF amfetamine sulfate
m-Methoxy-a-methylphenethylamine
m-Methoxyamphetamine
Mydrial
Norephedrane
Novydrine
NSC-27159
NSC-73713
Oktedrin
Ortedrine
Oxydess
Paredrine
Pasadena brand OF dextroamphetamine
Percomon
Phenamine
Phenedrine
Phenopromin
Phenylisopropylamine
Profamina
Propisamine
Psychedrine
rac-(2R)-1-phenylpropan-2-amine
rac-amphetamine
Raphetamine
Rhinalator
S(+)-amphetamine
Shire brand OF dextroamphetamine sulfate
Simpatedrin
Simpatina
Sulfate, amphetamine
Sulfate, dextroamphetamine
Sympamin
Sympamine
Sympatedrine
Thyramine
Vortech brand OF dextroamphetamine sulfate
Weckamine
α-methylbenzeneethaneamine
α-methylphenethylamine
β-aminopropylbenzene
β-phenylisopropylamine
|
|
10 |
|
Somatostatin |
Approved, Investigational |
Phase 2, Phase 3 |
|
38916-34-6, 51110-01-1 |
53481605 16129706 |
Synonyms:
(5S,8R,14R,17R,20R,23R,26R,29R,32R,35R)-38-[(2-{[(2R)-2-amino-1-hydroxypropylidene]amino}-1-hydroxyethylidene)amino]-20,35-bis(4-aminobutyl)-14,26,29-tribenzyl-7,10,13,16,19,22,25,28,31,34,37-undecahydroxy-32-[(C-hydroxycarbonimidoyl)methyl]-11-(1-hydroxyethyl)-17-[(1S)-1-hydroxyethyl]-8-(hydroxymethyl)-23-[(1H-indol-3-yl)methyl]-1,2-dithia-6,9,12,15,18,21,24,27,30,33,36-undecaazacyclononatriaconta-6,9,12,15,18,21,24,27,30,33,36-undecaene-5-carboxylate
ALA-GLY-CYCLO-[CYS-LYS-ASN-PHE-PHE-TRP-LYS-THR-PHE-THR-SER-CYS]
Growth hormone-inhibiting hormone (ghih)
L-ALANYLGLYCYL-L-CYSTEINYL-L-LYSYL-L-ASPARAGINYL-L-PHENYLALANYL-L-PHENYLALANYL-L-TRYPTOPHYL-L-LYSYL-L-THREONYL-L-PHENYLALANYL-L-THREONYL-L-SERYL-L-CYSTEINE CYCLIC (3-14) DISULFIDE
SOMATOSTATIN
SOMATOSTATIN-1
SOMATOSTATIN-14
SOMATOSTATINA
|
SOMATOSTATINE
SOMATOSTATINUM
Somatotropin release-inhibiting factor (srif)
Somatotropin release-inhibiting hormone
SRIF-14
SYNTHETIC GROWTH HORMONE RELEASE-INHIBITING HORMONE
SYNTHETIC SOMATOSTATIN-14
|
|
11 |
|
Ethanol |
Approved |
Phase 2, Phase 3 |
|
64-17-5 |
702 |
Synonyms:
[CH2Me(OH)]
[OEtH]
1-Hydroxyethane
ABLYSINOL
Absolute alcohol
Absolute ethanol
Absolute ethyl alcohol
Aethanol
Aethylalkohol
Alcare hand degermer
Alcohol
Alcohol (ethyl)
Alcohol anhydrous
Alcohol denatured
ALCOHOL DETERMINATION--ALCOHOL
Alcohol etilico
Alcohol etílico
Alcohol, absolute
Alcohol, Dehydrated
Alcohol, denatured
ALCOHOL, DILUTED
Alcohol, ethyl
Alcohol, grain
ALCOHOL, RUBBING
Alcohols
Alcool ethylique
Alcool éthylique
Alcool etilico
Algrain
Alkohol
Alkoholu etylowego
Aminoethanol
Anhydrol
Anhydrous alcohol
Anhydrous ethanol
Äthanol
Äthylalkohol
B3324
Beta-Aminoethanol
Beta-Aminoethyl Alcohol
Beta-Ethanolamine
Beta-Hydroxyethylamine
C2H5OH
Caswell No. 426
Colamine
Cologne spirit
Cologne spirits
Dehydrated alcohol
Dehydrated ethanol
Denatured alcohol
Denatured Alcohol Cd-10
Denatured Alcohol Cd-5
Denatured Alcohol Cd-5a
Denatured Alcohol Sd-1
Denatured Alcohol Sd-13a
Denatured Alcohol Sd-17
Denatured Alcohol Sd-23a
Denatured Alcohol Sd-28
Denatured Alcohol Sd-30
Denatured Alcohol Sd-39b
Denatured Alcohol Sd-39c
Denatured Alcohol Sd-3a
Denatured Alcohol Sd-40m
Denatured ethanol
Desinfektol el
Diluted alcohol
Distilled spirits
DRINKING ALCOHOL
E1510
Envision Conditioner Pdd 9020
ETA
Etanol
|
Etanolo
ETHANOL
éthanol
Ethanol 200 proof
Ethanol Absolute
Ethanol Absolute Bp
Ethanol Anhydrous
Ethanol Extra Pure
Ethanol solution
Ethanol, Silent Spirit
Ethicap
Ethyl alc
Ethyl alcohol
Ethyl Alcohol & Water, 10%
Ethyl Alcohol & Water, 20%
Ethyl Alcohol & Water, 30%
Ethyl Alcohol & Water, 40%
Ethyl Alcohol & Water, 5%
Ethyl Alcohol & Water, 50%
Ethyl Alcohol & Water, 60%
Ethyl Alcohol & Water, 70%
Ethyl Alcohol & Water, 80%
Ethyl Alcohol & Water, 95%
Ethyl Alcohol & Water, 96%
Ethyl alcohol anhydrous
Ethyl alcohol in alcoholic beverages
Ethyl alcohol usp
Ethyl Alcohol, Anhydrous
Ethyl Alcohol, Denatured
Ethyl hydrate
Ethyl hydroxide
Ethylol
Ethylolamine
EtOH
FEMA NO. 2419
Fermentation alcohol
Glycinol
Grain alcohol
Hinetoless
HSDB 531
Hydroxyethane
Infinity pure
Jaysol
Jaysol S
Lux
METHYLATED MINERAL
Methylated Spirit Mineralised
Methylcarbinol
Molasses alcohol
NCI-C03134
NSC-85228
PM-6193-200
Potato alcohol
Punctilious ethyl alcohol
Pyro
Reagent Alcohol
Silent spirit
SPIRIGEL
Spirit
Spirits OF wine
Spiritus vini
Spirt
SURG
Synasol
Tecsol
Tecsol C
Thanol
Thiofaco M-50
Undenatured ethanol
USAF EK-1597
VODKA
|
|
12 |
|
Modafinil |
Approved, Investigational |
Phase 3 |
|
68693-11-8 |
4236 |
Synonyms:
2-((Diphenylmethyl)sulfinyl)acetamide
2-((R)-(Diphenylmethyl)sulfinyl)acetamide
2-[(Diphenylmethyl)sulphinyl]acetamide
Alertec
Armodafinil
Benzhydrylsulfinylacetamide
CEP-1538
CEPA brand OF modafinil
Cephalon brand OF modafinil
Cephalon brand OF modafinil, reformulated
CRC-40476
CRL-40476
Dea No. 1680
DEP-1538
Draxis brand OF modafinil
Lafon brand OF modafinil
Merckle brand OF modafinil
Modafinil
|
Modafinil [Usan:Inn]
MODAFINIL CIV
Modafinilo
Modafinilo [Spanish]
Modafinilum
Modafinilum [Latin]
Moderateafinil
Modiodal
Nourypharma brand OF modafinil
Nuvigil
Provigil
Provigil®
R Modafinil
R-Modafinil
Sparlon
THN102 COMPONENT MODAFINIL
THN-102 COMPONENT MODAFINIL
Vigil
|
|
13 |
|
Copper |
Approved, Investigational |
Phase 2, Phase 3 |
|
7440-50-8 |
27099 |
Synonyms:
cobre
COPPER (II) ion
Copper(II) cation
Copper, ion (cu2+)
Cu
Cu(2+)
|
Cu(II)
Cu2+
cuivre
Cupric ion
cuprum
Kupfer
|
|
14 |
|
Disulfiram |
Approved |
Phase 2, Phase 3 |
|
97-77-8 |
3117 |
Synonyms:
1,1'-Dithiobis(N,N-diethylthioformamide)
Abstensil
Abstinil
Abstinyl
Accel Tet
Accel Tet-R
Akrochem Tetd
Alcophobin
Alk-Aubs
Allphar brand OF disulfiram
Altana pharma brand OF disulfiram
Ancazide Et
Antabus
Antabuse
ANTABUSE (TN)
Antabuse®|NSC-25953
Antadix
Antaenyl
Antaethan
Antaethyl
Antaetil
Antalcol
Antetan
Antethyl
Antetil
Anteyl
Anthethyl
Antiaethan
Anticol
Antietanol
Anti-Ethyl
Antietil
Antikol
Antivitium
Aversan
Averzan
Bis(diethylthiocarbamoyl) disulfide
Bis(diethylthiocarbamoyl) disulphide
Bohm brand OF disulfiram
Bonibal
Contralin
Contrapot
Cronetal
Dicupral
Disetil
Disulfan
Disulfide, tetraethylthiuram
DISULFIRAM
Disulfram
Disulfuram
Disulphiram
Disulphuram
Dumex brand OF disulfiram
Dupon 4472
Dupont fungicide 4472
Ekagom Dtet
Ekagom Teds
Ekagom Tetds
Ekaland Tetd
Ephorran
Espenal
Esperal
Etabus
Ethyl Thiram
Ethyl Thiudad
|
Ethyl Thiurad
Ethyl Tuads
Ethyl Tuads Rodform
Ethyl Tuex
Ethyldithiourame
Ethyldithiurame
Etyl Tuex
Exhoran
Exhorran
Gababentin
Hoca
Krotenal
N,N,N',n'-tetraethylthiuram disulfide
N,N,N',n'-tetraethylthiuram disulphide
Nocbin
Nocceler Tet
Nocceler Tet-G
Noxal
NSC-25953
Odyssey brand OF disulfiram
ORA102
ORA-102
Orphan brand OF disulfiram
Perkacit Tetd
Perkait Tetd
Refusal
Ro-Sulfiram
Sanceler Tet
Sanceler Tet-G
Sanofi synthelabo brand OF disulfiram
Soxinol Tet
Stopaethyl
Stopethyl
Stopety
Stopetyl
Super Rodiatox
TATD
Tenurid
Tenutex
TETD
Tetidis
Tetradin
Tetradine
Tetraethylthioperoxydicarbonic diamide
Tetraethylthioperoxydicarbonic diamide, ((H2N)C(S))2S2
Tetraethylthiram disulfide
Tetraethylthiram disulphide
Tetraethylthiuram
Tetraethylthiuram disulfide
Tetraethylthiuram disulphide
Tetraethylthiuram sulfide
Tetraethylthiuran disulfide
Tetraetil
Teturam
Teturamin
Thiocid
Thiophos
Thioscabin
Thireranide
Tillram
Tiuram
TTD
TTS
TTS X
Usaf b-33
|
|
15 |
|
Trioxsalen |
Approved |
Phase 3 |
|
3902-71-4 |
5585 |
Synonyms:
2',4,8-Trimethylpsoralen
2,5,9-Trimethyl-7H-furo(3,2-g)benzopyran-7-one
4,5',8-Trimethylpsoralen
4,8,5'-Trimethylpsoralen
6-Hydroxy-b,2,7-trimethyl-5-benzofuranacrylate, delta-lactone
6-Hydroxy-b,2,7-trimethyl-5-benzofuranacrylate, δ-lactone
6-Hydroxy-b,2,7-trimethyl-5-benzofuranacrylic acid, delta-lactone
6-Hydroxy-b,2,7-trimethyl-5-benzofuranacrylic acid, δ-lactone
6-Hydroxy-beta,2,7-trimethyl-5-benzofuranacrylate, delta-lactone
6-Hydroxy-beta,2,7-trimethyl-5-benzofuranacrylic acid, delta-lactone
6-Hydroxy-β,2,7-trimethyl-5-benzofuranacrylate, δ-lactone
|
6-Hydroxy-β,2,7-trimethyl-5-benzofuranacrylic acid, δ-lactone
ICN brand OF trioxsalen
Trimethylpsoralen
Trioxisaleno
Trioxisalenum
TRIOXSALEN
Trioxysalen
Trioxysalene
Trioxysalenum
Trisoralen
|
|
16 |
|
Vorinostat |
Approved, Investigational |
Phase 2, Phase 3 |
|
149647-78-9 |
5311 |
Synonyms:
18F Suberoylanilide hydroxamic acid
18F-SAHA
18F-Suberoylanilide hydroxamic acid
Merck brand OF vorinostat
MK0683
MK-0683
MK-0683|MK0683|SAHA|suberoylanilide hydroxamic acid|Zolinza®
N Hydroxy n' phenyloctanediamide
N1 Hydroxy N8 phenyloctanediamide
N1-Hydroxy-N8-phenyloctanediamide
NHNPODA
N-Hydroxy-n'-phenyloctanediamide
N-Hyrdroxy-n'-phenyloctanediamide
|
Octanedioate hydroxyamide phenylamide
Octanedioic acid hydroxyamide phenylamide
SAHA
SHH
Suberanilohydroxamate
Suberanilohydroxamic acid
Suberoyl anilide hydroxamic acid
Suberoylanilide hydroxamate
Suberoylanilide hydroxamic acid
VORINOSTAT
Vorinostatum
Zolinza
|
|
17 |
|
Vincristine |
Approved, Investigational |
Phase 3 |
|
2068-78-2, 57-22-7 |
5978 |
Synonyms:
(+)-Vincristine
22-OXOVINCALEUKOBLASTIN
22-oxo-Vincaleukoblastine
22-Oxovincaleukoblastine
22-oxovincaleukoblastine|kyocristine|leurocristine sulfate|NSC-67574|Oncovin®
37231
Cellcristin
Citomid
Farmistin
Indole alkaloid
KYOCRISTINE
LCR
Leucristine
Leurocristine
LEUROCRISTINE SULFATE
LILLY-37231
Marqibo
MARQIBO KIT
NSC-67574
Onco TCS
Oncovin
Oncovine
Onkocristin
PFS, Vincasar
|
Sulfate, vincristine
Tecnocris
VCR
VIN
Vincasar
Vincasar PFS
VINCREX
Vincristin
Vincristin bristol
Vincristin medac
Vincristina
Vincristina [DCIT]
VINCRISTINE
Vincristine sulfate
VINCRISTINE SULFATE PFS
VINCRISTINUM
Vincristinum [INN-Latin]
Vincrisul
Vincrstine
Vincrystine
Vinkristin
Vintec
Z-D-Val-lys(Z)-OH
|
|
18 |
|
Vinblastine |
Approved |
Phase 3 |
|
865-21-4 |
241903 13342 |
Synonyms:
(2a,2'b,3b,4a,5b)-VINCALEUKOBLASTINE
(2ALPHA,2'BETA,3BETA,4ALPHA,5BETA)-VINCALEUKOBLASTINE
(2Α,2'β,3β,4α,5β)-vincaleukoblastine
[3H]-VINBLASTINE
29060-LE|Velban®|Velbe®|vincaleucoblastin|vincaleukoblastine
Cell pharm brand OF vinblastine sulfate
Cellblastin
EG labo brand OF vinblastine sulfate
Faulding brand OF vinblastine sulfate
Gastrozepin brand OF vinblastine sulfate
Gry brand OF vinblastine sulfate
Hexal brand OF vinblastine sulfate
Lemblastine
Lemery brand OF vinblastine sulfate
Lilly brand OF vinblastine sulfate
Nincaluicolflastine
NSC-47842
Rozevin
|
Sulfate, vinblastine
Velban
Velbe
Vinblastin
Vinblastin hexal
Vinblastina
Vinblastina [Dcit]
Vinblastina lilly
Vinblastine
Vinblastine sulfate
Vinblastinsulfat-gry
Vinblastinum
Vinblastinum [INN-Latin]
Vincaleucoblastin
Vincaleucoblastine
Vincaleukoblastine
Vincoblastine
VLB
|
|
19 |
|
Carbidopa |
Approved |
Phase 3 |
|
28860-95-9 |
34359 38101 |
Synonyms:
(-)-L-a-Hydrazino-3,4-dihydroxy-a-methylhydrocinnamate
(-)-L-a-Hydrazino-3,4-dihydroxy-a-methylhydrocinnamic acid
(-)-L-alpha-Hydrazino-3,4-dihydroxy-alpha-methylhydrocinnamate
(-)-L-alpha-Hydrazino-3,4-dihydroxy-alpha-methylhydrocinnamic acid
(-)-L-ALPHA-HYDRAZINO-3,4-DIHYDROXY-ALPHA-METHYLHYDROCINNAMIC ACID MONOHYDRATE
(-)-L-Α-hydrazino-3,4-dihydroxy-α-methylhydrocinnamate
(-)-L-Α-hydrazino-3,4-dihydroxy-α-methylhydrocinnamic acid
(2S)-3-(3,4-DIHYDROXYPHENYL)-2-HYDRAZINYL-2-METHYLPROPANOIC ACID HYDRATE
(2S)-3-(3,4-DIHYDROXYPHENYL)-2-HYDRAZINYL-2-METHYLPROPANOIC ACID MONOHYDRATE
(AlphaS)-a-hydrazino-3,4-dihydroxy-a-methylbenzenepropanoate
(AlphaS)-a-hydrazino-3,4-dihydroxy-a-methylbenzenepropanoic acid
(AlphaS)-alpha-hydrazino-3,4-dihydroxy-alpha-methylbenzenepropanoate
(AlphaS)-alpha-hydrazino-3,4-dihydroxy-alpha-methylbenzenepropanoic acid
(ALPHAS)-ALPHA-HYDRAZINO-3,4-DIHYDROXY-ALPHA-METHYLBENZENEPROPANOIC ACID MONOHYDRATE
(AlphaS)-α-hydrazino-3,4-dihydroxy-α-methylbenzenepropanoate
(AlphaS)-α-hydrazino-3,4-dihydroxy-α-methylbenzenepropanoic acid
(S)-(−)-carbidopa
(S)-(-)-Carbidopa
(S)-(-)-CARBIDOPA HYDRATE
(S)-(−)-CARBIDOPA HYDRATE
(S)-Carbidopa
(S)-CARBIDOPA HYDRATE
|
(αS)-α-hydrazino-3,4-dihydroxy-α-methylbenzenepropanoic acid
Carbidopa
Carbidopa (anhydrous)
CARBIDOPA ANHYDROUS
CARBIDOPA HYDRATE
CARBIDOPA MONOHYDRATE
Carbidopa, (R)-isomer
Carbidopa, (S)-isomer
Carbidopum
CARBIDOPUM MONOHYDRICUM
CDP536
Duodopa®|Lodosyn®|MK 486
L-3-(3,4-Dihydroxyphenyl)-2-methyl-2-hydrazinopropionate
L-3-(3,4-Dihydroxyphenyl)-2-methyl-2-hydrazinopropionic acid
L-ALPHA-(3,4-DIHYDROXYBENZYL)-ALPHA-HYDRAZINOPROPIONIC ACID MONOHYDRATE
L-alpha-Methyldopahydrazine
L-a-Methyldopahydrazine
Lodosin
Lodosyn
L-Α-methyldopahydrazine
Methyldopahydrazine
MK-486
|
|
20 |
|
Bevacizumab |
Approved, Investigational |
Phase 3 |
|
216974-75-3 |
135329020 |
Synonyms:
12-IGG1
ANTIVEGF
Anti-VEGF Humanized Monoclonal Antibody
Anti-VEGF monoclonal antibody
AVA-1
AVASTIN
Bevacizumab
BEVACIZUMAB BETA
bevacizumab-awwb
|
BI 695502
BS-503A
FKB-238
HLX04
HLX-04
R-435
RG-435
RHUMAB-
rhuMAb-VEGF
|
|
21 |
|
Lomustine |
Approved, Investigational |
Phase 3 |
|
13010-47-4 |
3950 |
Synonyms:
1-(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea
1-(2-Chloroethyl)-3-cyclohexylnitrosourea
Belustine
Bristol myers squibb brand OF lomustine
Bristol-myers squibb brand OF lomustine
CCNU
CCN-U
Cecenu
CeeNU
Chloroethylcyclohexylnitrosourea
CINU
|
Cyclohexyl chloroethyl nitrosourea
Gleostine
Lomustina
LOMUSTINE
Lomustine medac brand
Lomustinum
Medac brand OF lomustine
N-(2-Chloroethyl)-n'-cyclohexyl-N-nitrosourea
NSC-79037
Rhône poulenc rorer brand OF lomustine
Rhône-poulenc rorer brand OF lomustine
|
|
22 |
|
Ascorbic acid |
Approved, Nutraceutical |
Phase 3 |
|
50-81-7 |
54676860 54670067 5785 |
Synonyms:
(+)-Ascorbate
(+)-Ascorbic acid
(+)-Sodium L-ascorbate
[<sup>14</sup>C]-ascorbic acid
3-keto-L-Gulofuranolactone
3-oxo-L-Gulofuranolactone
AA
Acid, ascorbic
Acid, L-ascorbic
Acide ascorbique
Acido ascorbico
ácido ascórbico
Acidum ascorbicum
Acidum ascorbinicum
Adenex
Allercorb
Antiscorbic vitamin
Antiscorbutic vitamin
arco-Cee
Ascoltin
ASCOR
Ascorb
Ascor-b.i.d.
Ascorbajen
Ascorbate
Ascorbate radical
Ascorbate, ferrous
Ascorbate, magnesium
Ascorbate, sodium
ASCORBIC ACID
Ascorbic acid radical
Ascorbic acid, monosodium salt
Ascorbicab
Ascorbicap
Ascorbicin
Ascorbin
Ascorbinsaeure
Ascorbinsäure
Ascorbutina
Ascorin
Ascorteal
Ascorvit
Cantan
Cantaxin
Catavin C
Ce lent
Cebicure
Cebid
Cebion
Cebione
Cecon
Cee-caps TD
Cee-vite
Cegiolan
Ceglion
Ceklin
Celaskon
Celin
Cell C
Cemagyl
Ce-mi-lin
Cemill
Cenetone
Cenolate
Cereon
Cergona
Cescorbat
Cetamid
Cetane
Cetane-caps TC
Cetane-caps TD
Cetebe
Cetemican
Cevalin
Cevatine
Cevex
Cevi-bid
Cevimin
Ce-vi-sol
Cevital
Cevitamate
Cevitamic acid
Cevitamin
Cevitan
Cevitex
Cewin
Chewcee
|
Ciamin
Cipca
Citriscorb
Citrovit
C-Level
C-Long
Colascor
Concemin
C-Quin
C-Span
C-Vimin
Davitamon C
Di-L-ascorbate, magnesium
Dora-C-500
Duoscorb
e 300
e300
e-300
Ferrous ascorbate
gamma-Lactone L-threo-hex-2-enonate
gamma-Lactone L-threo-hex-2-enonic acid
HiCee
Hybrin
ido-C
Juvamine
Kangbingfeng
Kyselina askorbova
L Ascorbic acid
L(+)-Ascorbate
L-(+)-Ascorbate
L(+)-Ascorbic acid
L-(+)-Ascorbic acid
L-3-Ketothreohexuronic acid lactone
Laroscorbine
L-Ascorbate
L-Ascorbic acid
Lemascorb
Liqui-cee
L-Lyxoascorbate
L-Lyxoascorbic acid
L-threo-Ascorbic acid
L-Xyloascorbate
L-Xyloascorbic acid
Magnesium ascorbate
Magnesium ascorbicum
Magnesium di L ascorbate
Magnesium di-L-ascorbate
Magnorbin
Meri-c
Monodehydroascorbate radical
Monodehydroascorbic acid radical
Natrascorb
Natrascorb injectable
Planavit C
Proscorbin
Redoxon
Ribena
Ronotec 100
Rontex 100
Roscorbic
Rovimix C
Scorbacid
Scorbu C
Scorbu-C
Secorbate
Semidehydroascorbate
Semidehydroascorbic acid
Sodascorbate
Sodium ascorbate
Suncoat VC 40
Testascorbic
VASC
Vicelat
Vicin
Vicomin C
Viforcit
Viscorin
Viscorin 100m
Vitace
Vitacee
Vitacimin
Vitacin
Vitamin C
Vitamina C
Vitamisin
Vitascorbol
Xitix
|
|
23 |
|
Aspartic acid |
Approved, Nutraceutical |
Phase 3 |
|
56-84-8 |
5960 |
Synonyms:
(+)-Aspartate
(+)-Aspartic acid
(+-)-Aspartic acid
(2S)-2-AMINOBUTANEDIOIC ACID
(2S)-2-AMINOSUCCINIC ACID
(2S)-Aspartate
(2S)-Aspartic acid
(L)-Aspartate
(L)-Aspartic acid
(R)-2-Aminosuccinate
(R,S)-Aspartic acid
(S)-(+)-Aspartate
(S)-(+)-Aspartic acid
(S)-2-Aminobutanedioate
(S)-2-Aminobutanedioic acid
(S)-2-Aminosuccinate
(S)-2-Aminosuccinic acid
(S)-Aminobutanedioate
(S)-Amino-butanedioate
(S)-Aminobutanedioic acid
(S)-Amino-butanedioic acid
(S)-Aspartate
(S)-Aspartic acid
[<sup>3</sup>H]-L-aspartate|[<sup>3</sup>H]-L-aspartic acid
2-Amino-3-methylsuccinate
2-Amino-3-methylsuccinic acid
2-Aminosuccinate
2-Aminosuccinic acid
ácido aspártico
Acidum asparticum
alpha-Aminosuccinate
alpha-Aminosuccinic acid
Aminosuccinate
Ammonium aspartate
Asp
Asparagate
Asparagic acid
Asparaginate
Asparaginic acid
Asparatate
ASPARTate
Aspartate magnesium hydrochloride
Aspartate, ammonium
Aspartate, calcium
Aspartate, dipotassium
Aspartate, disodium
Aspartate, magnesium
Aspartate, monopotassium
Aspartate, monosodium
Aspartate, potassium
Aspartate, sodium
|
ASPARTIC ACID
Aspartic acid, ammonium salt
Aspartic acid, calcium salt
Aspartic acid, dipotassium salt
Aspartic acid, disodium salt
Aspartic acid, hydrobromide
Aspartic acid, hydrochloride
Aspartic acid, magnesium (1:1) salt, hydrochloride, trihydrate
Aspartic acid, magnesium (2:1) salt
Aspartic acid, magnesium-potassium (2:1:2) salt
Aspartic acid, monopotassium salt
Aspartic acid, monosodium salt
Aspartic acid, potassium salt
Aspartic acid, sodium salt
Calcium aspartate
D
Dipotassium aspartate
Disodium aspartate
FEMA NO. 3656
H-Asp-OH
Hydrobromide aspartic acid
Hydrochloride aspartic acid
Hydrochloride, aspartate magnesium
L Aspartate
L Aspartic acid
L-(+)-Aspartate
L-(+)-Aspartic acid
L-Aminosuccinate
L-Aminosuccinic acid
L-Asp
L-Asp|L-aspartate
L-Asparagate
L-Asparagic acid
L-Asparaginate
L-Asparaginic acid
L-Asparaginsaeure
L-Asparaginsäure
L-Aspartate
L-Aspartic acid
Magnesiocard
Magnesium aspartate
MG 5 Longoral
MG5Longoral
MG-5-Longoral
Monopotassium aspartate
Monosodium aspartate
NSC-3973
Poly-DL-succinimide
Polysuccinimide
Potassium aspartate
Sodium aspartate
|
|
24 |
|
Palifosfamide |
Investigational |
Phase 3 |
|
31645-39-3 |
100427 |
Synonyms:
Ifosfamide mustard
Ifosforamide mustard
IPAM
Iphosphoramide mustard
IPM
Isophosphamide mustard
Isophosphoramide mustard
N,N'-BIS-(2-CHLOROETHYL)PHOSPHORIC ACID
|
N,N'-di-(2-chloroethyl)phosphorodiamidic acid
NN'-Bis-(2-chloroethyl)phosphate
NN'-Bis-(2-chloroethyl)phosphoric acid
NSC-297900
Palifosfamide
Palifosfamide-tris
ZIO-201
Zio-201isophosphamide mustard
|
|
25 |
|
Diethyl ether |
Experimental |
Phase 3 |
|
60-29-7 |
3283 |
Synonyms:
1,1'-Oxybisethane
3-Oxapentane
Aether
Aether pro narcosi
Anesthetic ether
Diethyl ether
Diethyl oxide
Diethylaether
Ether
|
Ether, diethyl
Ether, ethyl
Ethoxyethane
Ethyl ether
Ethyl oxide
NSC-100036
Pronarcol
R-610
SOLVENT ETHER
|
|
26 |
|
Dihematoporphyrin ether |
Investigational |
Phase 3 |
|
97067-70-4 |
|
Synonyms:
bis-1-(8-(1-hydroxyethyl)deuteroporphyrin-3-yl)ethyl ether
DHP ether
|
|
|
27 |
|
Nimotuzumab |
Investigational |
Phase 3 |
|
780758-10-3 |
|
Synonyms:
HR3
NIMOTUZUMAB
THERACIM-HR3
|
THERALOC
THERALOC THERACIM
|
|
28 |
|
Dianhydrogalactitol |
Investigational |
Phase 3 |
|
23261-20-3 |
|
Synonyms:
1,2,5,6-Dianhydrogalactitol
1,2:5,6-Dianhdrogalactitol
1,2:5,6-Dianhydrogalactitol
1,2-5,6-Dianhydrogalactitol
|
Dianhydrogalactitol
Diepoxydulcitol
Diepoxygalactitol
|
|
29 |
|
Protective Agents |
|
Phase 3 |
|
|
|
30 |
|
Antioxidants |
|
Phase 3 |
|
|
|
31 |
|
Interferon-alpha |
|
Phase 3 |
|
|
|
32 |
|
Vitamins |
|
Phase 3 |
|
|
|
33 |
|
Dopamine Uptake Inhibitors |
|
Phase 3 |
|
|
|
34 |
|
Edotreotide |
|
Phase 2, Phase 3 |
|
|
23724894 |
Synonyms:
2-(4-{[(1-{[10-(4-aminobutyl)-4-[(1,3-dihydroxybutan-2-yl)-C-hydroxycarbonimidoyl]-6,9,12,15,18-pentahydroxy-7-(1-hydroxyethyl)-16-[(4-hydroxyphenyl)methyl]-13-[(1H-indol-3-yl)methyl]-1,2-dithia-5,8,11,14,17-pentaazacycloicosa-5,8,11,14,17-pentaen-19-yl]-C-hydroxycarbonimidoyl}-2-phenylethyl)-C-hydroxycarbonimidoyl]methyl}-7,10-bis(carboxymethyl)-1,4,7,10-tetraazacyclododecan-1-yl)acetate
|
DOTA-Tyr<sup>3</sup>-octreotide|DOTA<sup>0</sup>-Phe<sup>1</sup>-Tyr<sup>3</sup>-octreotide|Ga-DOTA-TOC|Ga-DOTATOC|SMT487|SomaKit TOC®
|
|
35 |
|
Trace Elements |
|
Phase 2, Phase 3 |
|
|
|
36 |
|
Micronutrients |
|
Phase 2, Phase 3 |
|
|
|
37 |
|
Anesthetics |
|
Phase 3 |
|
|
|
38 |
|
Central Nervous System Stimulants |
|
Phase 3 |
|
|
|
39 |
|
Anesthetics, General |
|
Phase 3 |
|
|
|
40 |
|
Copper Supplement |
|
Phase 2, Phase 3 |
|
|
|
41 |
|
Hematoporphyrin Derivative |
|
Phase 3 |
|
|
|
42 |
|
Anesthetics, Inhalation |
|
Phase 3 |
|
|
|
43 |
|
Hematoporphyrins |
|
Phase 3 |
|
|
|
44 |
|
N-Methylaspartate |
|
Phase 3 |
|
|
|
45 |
|
Immunoglobulin G |
|
Phase 2, Phase 3 |
|
|
|
46 |
|
Endothelial Growth Factors |
|
Phase 2, Phase 3 |
|
|
|
47 |
|
Fluorophosphate |
|
Phase 3 |
|
|
|
48 |
|
D-Leucine |
Experimental, Investigational, Nutraceutical |
Phase 3 |
|
328-38-1, 61-90-5 |
439524 6106 |
Synonyms:
(2R)-2-Amino-4-methylpentanoate
(2R)-2-Amino-4-methylpentanoic acid
(2S)-2-Amino-4-methylpentanoate
(2S)-2-Amino-4-methylpentanoic acid
(2S)-2-AMINO-4-METHYL-PENTANOIC ACID
(2S)-a-2-Amino-4-methylvalerate
(2S)-a-2-Amino-4-methylvaleric acid
(2S)-a-Leucine
(2S)-alpha-2-Amino-4-methylvalerate
(2S)-alpha-2-Amino-4-methylvaleric acid
(2S)-alpha-Leucine
(2S)-Α-2-amino-4-methylvalerate
(2S)-Α-2-amino-4-methylvaleric acid
(2S)-Α-leucine
(R)-(−)-leucine
(R)-(-)-Leucine
(R)-Leucine
(S)-(+)-Leucine
(S)-2-Amino-4-methylpentanoate
(S)-2-Amino-4-methylpentanoic acid
(S)-2-Amino-4-methylvalerate
(S)-2-Amino-4-methylvaleric acid
(S)-Leucine
2-Amino-4-methylvalerate
2-Amino-4-methylvaleric acid
4-Methyl-L-norvaline
|
D-2-Amino-4-methylvalerate
D-2-Amino-4-methylvaleric acid
DLE
D-Leucin
D-Leuzin
E641
FEMA NO. 3297
L
L-(+)-Leucine
L-a-Aminoisocaproate
L-a-Aminoisocaproic acid
L-alpha-Aminoisocaproate
L-alpha-Aminoisocaproic acid
Leu
LEUCINE
Leucine, L isomer
Leucine, L-isomer
LEUCOVORIN
L-Isomer leucine
L-LEU
L-Leucin
L-LEUCINE
L-Leuzin
L-Α-AMINOISOCAPROIC ACID
NSC-46709
|
|
49 |
|
Pemetrexed |
Approved, Investigational |
Phase 2 |
|
150399-23-8, 137281-23-3 |
60843 446556 135565230 |
Synonyms:
(2R)-2-{[4-(2-{4-hydroxy-2-imino-1H,2H,7H-pyrrolo[2,3-D]pyrimidin-5-yl}ethyl)phenyl]formamido}pentanedioate
ALIMTA
Alimta®|LY-231514
Disodium, pemetrexed
LY-2315
LY231514
|
LY-231514
MTA
N-(4-(2-(2-Amino-3,4-dihydro-4-oxo-7H-pyrrolo(2,3-D)pyrimdin-5-yl)ethyl)benzoyl)glutamic acid
NSC-698037
Pemetrexed
Pemetrexed disodium
|
|
50 |
|
Arsenic trioxide |
Approved, Investigational |
Phase 1, Phase 2 |
|
1327-53-3 |
518740 |
Synonyms:
Acide Arsenieux
Acide Arsenieux [French]
Anhydride Arsenieux
Anhydride Arsenieux [French]
Arseni trioxydum
Arsenic Blanc
Arsenic Blanc [French]
Arsenic Oxide
Arsenic oxidearsenous trioxide
Arsenic Sesquioxide
ARSENIC TRIOXIDE
Arsenic Trioxide [UN1561] [Poison]
Arsenic(III) oxide
Arsenic, White
arsénico trióxido
Arsenicum Album
Arsenigen Saure
Arsenigen Saure [German]
Arsenious acid
Arsenious Acid Anhydride
Arsenious Oxide
Arsenious trioxide
Arsenite
|
Arsenolite
Arsenous Acid
Arsenous Acid Anhydride
Arsenous anhydride
Arsenous Oxide
Arsenous Oxide Anhydride
Arsentrioxide
Arsodent
Claudelite
Claudetite
Crude Arsenic
Diarsenic oxide
Diarsenic trioxide
Di-Arsenic Trioxide
Diarsonic Trioxide
HSDB 419
Naonobin
Oxyde Arsenieux [ISO-French]
Poison Flour
TRISENOX
Trixenox
White Arsenic
|
|
Interventional clinical trials:
(show top 50)
(show all 1332)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
A Prospective, Single-Blinded, Randomized Study of Awake vs Intubated General Anesthesia in Patients Undergoing Elective Craniotomy for Supratentorial Glioma Resection |
Completed |
NCT02193568 |
Phase 4 |
|
2 |
Seizure Treatment IN Glioma (STING): Comparing a Treatment Strategy With Levetiracetam Versus Treatment With Valproic Acid in Glioma Patients With a First Seizure |
Recruiting |
NCT03048084 |
Phase 4 |
Levetiracetam;Valproic Acid |
3 |
An Open Label, Multi-center Roll-over Study to Assess Long-term Effect in Pediatric Patients Treated With Tafinlar (Dabrafenib) and/or Mekinist (Trametinib) |
Recruiting |
NCT03975829 |
Phase 4 |
dabrafenib;trametinib |
4 |
A Phase IV, Prospective, Open-Label, Parallel Study Evaluating the Effect of an Adjunctive Anti-Seizure Medication Using a Glutamatergic Modulator in Patients With Focal Epilepsy and High-Grade Glioma |
Recruiting |
NCT04650204 |
Phase 4 |
Anticonvulsant Agent;Perampanel |
5 |
Open Label, Multi-center Roll-over Study to Assess Long Term Safety in Patients Who Have Completed a Global Novartis or GSK Sponsored Dabrafenib and/or Trametinib Study |
Recruiting |
NCT03340506 |
Phase 4 |
dabrafenib;trametinib |
6 |
Pilot Study Evaluating the Optimization of the ORBEYE Blue Light Filter During Fluorescence-Guided Resection of Gliomas |
Recruiting |
NCT04937244 |
Phase 4 |
|
7 |
A Study of CIK in Combination With Temozolomide With and Without Radiation in Adults With Advanced Malignant Gliomas |
Not yet recruiting |
NCT02496988 |
Phase 4 |
Temozolomide |
8 |
Treatment of Children and Adolescents With Diffuse Intrinsic Pontine Glioma and High Grade Glioma |
Unknown status |
NCT00278278 |
Phase 3 |
cisplatin;etoposide;ifosfamide;lomustine;methotrexate;prednisone;vincristine sulfate |
9 |
Phase 3 Study of Carmustine Sustained Release Implant (CASANT) to Treat Newly Diagnosed Malignant Glioma |
Unknown status |
NCT01656980 |
Phase 3 |
Carmustine |
10 |
A Single-blind, Randomized, Clinical Trial Comparing the Efficacy of 6 Cycles Versus 12 Cycles Temozolomide Regimens in Adjuvant Treatment of Patients With Brain High Grade Glioma |
Unknown status |
NCT03633552 |
Phase 3 |
Temozolomide |
11 |
A Study Evaluating Dexamfetamine Sulphate in Patients With Glioma Suffering From Severe Asthenia. A Phase III Double-blind Randomized Placebo-controlled Trial |
Unknown status |
NCT02363075 |
Phase 3 |
Dexamfetamine sulphate;placebo |
12 |
Cognitive Rehabilitation of Glioma Patients: a Prospective, Randomized Study |
Unknown status |
NCT00256425 |
Phase 3 |
|
13 |
A Phase III Study Comparing Two Carboplatin Containing Regimens for Children and Young Adults With Previously Untreated Low Grade Glioma |
Unknown status |
NCT02455245 |
Phase 3 |
Carboplatin;Vincristine |
14 |
Ultimate Low Grade Glioma Study |
Unknown status |
NCT00003015 |
Phase 3 |
carboplatin;vincristine sulfate |
15 |
Barrow 5-ALA Intraoperative Confocal Evaluation Trial |
Unknown status |
NCT01502280 |
Phase 3 |
5-Aminolevulinic acid (ALA);Placebo - ascorbic acid |
16 |
A Phase III Trial on Adjuvant Standard Temozolomide Chemotherapy With or Without Interferon-alpha in Newly Diagnosed High-grade Gliomas |
Unknown status |
NCT01765088 |
Phase 3 |
Temozolomide;α-IFN |
17 |
A Phase II Study of Observation in Favorable Low-Grade Glioma and a Phase II Study of Radiation With or Without PCV Chemotherapy in Unfavorable Low-Grade Glioma |
Completed |
NCT00003375 |
Phase 2, Phase 3 |
lomustine;procarbazine hydrochloride;vincristine sulfate |
18 |
A Phase III Comparison of Hyperfractionated Radiation Therapy (RT) With BCNU and Conventional RT With BCNU for Supratentorial Malignant Glioma |
Completed |
NCT03722355 |
Phase 3 |
Carmustine |
19 |
Randomized Study of Normal-fractionated Radiotherapy Versus Hypofractionated Radiotherapy Versus Chemotherapy in Patients Over 60 Years With Malignant Glioma |
Completed |
NCT00820963 |
Phase 3 |
temozolomide |
20 |
NOA-04 Randomized Phase III Study of Sequential Radiochemotherapy of Anaplastic Glioma With PCV or Temozolomide |
Completed |
NCT00717210 |
Phase 3 |
Temozolomide |
21 |
Prospective Randomized Trial of Hypofractionated Radiotherapy Versus Conventional Radiotherapy in Diffuse Brainstem Glioma in Children. |
Completed |
NCT01635140 |
Phase 3 |
|
22 |
Clinical Study to Assess the Positive Predictive Value of NPC-07 Induced Tissue Fluorescence in Patients With Malignant Glioma (WHO Grades III/IV) |
Completed |
NCT01167322 |
Phase 3 |
NPC-07 for oral administration |
23 |
A Phase III Randomized, Double-Blind Placebo Controlled Study of Armodafinil (Nuvigil®) To Reduce Cancer-Related Fatigue in Patients With High Grade Glioma |
Completed |
NCT01781468 |
Phase 3 |
armodafinil 150 mg;armodafinil 250 mg |
24 |
3.0T High-field Intraoperative MRI Guided Extent of Resection in Cerebral Glioma Surgery: a Single Center Prospective Randomized Triple-blind Controlled Clinical Trial |
Completed |
NCT01479686 |
Phase 3 |
|
25 |
PET/CT Imaging of Malignant Glioma With Somatostatin Analog 68Ga-DOTATOC |
Completed |
NCT01460706 |
Phase 2, Phase 3 |
[68Ga]DOTATOC |
26 |
DIRECT (DIsulfiram REsponse as add-on to ChemoTherapy in Recurrent) Glioblastoma: A Randomized Controlled Trial |
Completed |
NCT02678975 |
Phase 2, Phase 3 |
Disulfiram;Alkylating Agents |
27 |
18F-DOPA PET Imaging: an Evaluation of Biodistribution and Safety |
Completed |
NCT03042416 |
Phase 3 |
18F-DOPA |
28 |
Impact of Surgery on the Treatment of Supratentorial Malignant Gliomas in Subjects Aged 70 and Over |
Completed |
NCT02892708 |
Phase 3 |
|
29 |
Primary Chemotherapy With Temozolomide Versus Radiotherapy in Patients With Low Grade Gliomas After Stratification for Genetic 1p Loss: A Phase III Study |
Completed |
NCT00182819 |
Phase 3 |
temozolomide |
30 |
Fluorescence-guided Resection of Malignant Gliomas With 5-Aminolevulinic Acid (5-ALA) vs. Conventional Resection |
Completed |
NCT00241670 |
Phase 3 |
5-aminolevulinic acid (5-ALA) |
31 |
A Randomized Prospective Two Arm Clinical Trial of High Light Dose And Low Light Dose PDT in the Treatment of Recurrent Malignant Supratentorial Gliomas Using Porfimer Sodium [Photofrin] |
Completed |
NCT00118222 |
Phase 3 |
porfimer sodium |
32 |
A Phase 3 Study of Selumetinib (NSC# 748727) or Selumetinib in Combination With Vinblastine for Non-NF1, Non-TSC Patients With Recurrent or Progressive Low-Grade Gliomas (LGGs) Lacking BRAFV600E or IDH1 Mutations |
Recruiting |
NCT04576117 |
Phase 3 |
Selumetinib Sulfate;Vinblastine Sulfate |
33 |
Phase III Intergroup Study of Radiotherapy With Concomitant and Adjuvant Temozolomide Versus Radiotherapy With Adjuvant PCV Chemotherapy in Patients With 1p/19q Co-deleted Anaplastic Glioma or Low Grade Glioma |
Recruiting |
NCT00887146 |
Phase 3 |
concomitant temozolomide (TMZ);procarbazine;adjuvant temozolomide (TMZ);CCNU;vincristine |
34 |
International Cooperative Phase III Trial of the HIT-HGG Study Group for the Treatment of High Grade Glioma, Diffuse Intrinsic Pontine Glioma, and Gliomatosis Cerebri in Children and Adolescents < 18 Years.(HIT-HGG-2013) |
Recruiting |
NCT03243461 |
Phase 3 |
Temozolomide + Valproic Acid |
35 |
A Phase 3 Randomized Study of Selumetinib Versus Carboplatin/Vincristine in Newly Diagnosed or Previously Untreated Neurofibromatosis Type 1 (NF1) Associated Low-Grade Glioma (LGG) |
Recruiting |
NCT03871257 |
Phase 3 |
Carboplatin;Selumetinib Sulfate;Vincristine Sulfate |
36 |
A Phase 3 Randomized Non-Inferiority Study of Carboplatin and Vincristine Versus Selumetinib (NSC# 748727) in Newly Diagnosed or Previously Untreated Low-Grade Glioma (LGG) Not Associated With BRAFV600E Mutations or Systemic Neurofibromatosis Type 1 (NF1) |
Recruiting |
NCT04166409 |
Phase 3 |
Carboplatin;Selumetinib Sulfate;Vincristine Sulfate |
37 |
Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication |
Recruiting |
NCT05476939 |
Phase 3 |
Everolimus;ONC201 |
38 |
A Multicenter, Prospective, Open and Single Arm Clinical Study of Nimotuzumab Combined With Concurrent Radiochemotherapy in the Treatment of Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG) in Children |
Recruiting |
NCT04532229 |
Phase 3 |
Nimotuzumab+CRT(concurrent IMRT and TMZ) |
39 |
ONC201 for the Treatment of Newly Diagnosed H3 K27M-mutant Diffuse Glioma Following Completion of Radiotherapy: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study |
Recruiting |
NCT05580562 |
Phase 3 |
ONC201;ONC201 + Placebo |
40 |
Improvement of Functional Outcome for Patients With Newly Diagnosed Grade II or III Glioma With Co-deletion of 1p/19q - IMPROVE CODEL: the NOA-18 Trial |
Recruiting |
NCT05331521 |
Phase 3 |
CETEG;PCV |
41 |
Efficacy of Post-radiation Adjuvant Temozolomide Chemotherapy in Residue Low-grade Glioma |
Recruiting |
NCT01649830 |
Phase 3 |
Temozolomide |
42 |
Neuropsychological and Oncological Outcomes in Grade 2 or 3 Glioma Patients Undergoing Postoperative Modern Radiotherapy - A Prospective Follow-up Study |
Recruiting |
NCT03534050 |
Phase 2, Phase 3 |
|
43 |
18F-Fluciclovine PET Imaging for Detecting High Grade Glioma Recurrence After Radiochemotherapy |
Recruiting |
NCT05479136 |
Phase 3 |
PET imaging with 18F fluciclovine |
44 |
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Basket Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab In Patients With Anti-N-Methyl-D-Aspartic Acid Receptor (NMDAR) Or Anti-Leucine-Rich Glioma-Inactivated 1 (LGI1) Encephalitis |
Recruiting |
NCT05503264 |
Phase 3 |
Satralizumab |
45 |
Radiotherapy Versus Radiotherapy Combined With Temozolomide in High-risk Low-grade Gliomas After Surgery |
Recruiting |
NCT04316039 |
Phase 2, Phase 3 |
Temozolomide |
46 |
A Phase III Randomized Trial of Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab (Avastin) With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed Glioblastoma (GBM) |
Recruiting |
NCT05271240 |
Phase 3 |
Repeated Superselective Intraarterial Cerebral infusion (SIACI) of Bevacizumab (Avastin) with Temozolomide and Radiation;Temozolomide and Radiation Alone |
47 |
A Study on β-elemene as Maintain Treatment for Complete Remission Patients of Newly Diagnosed Malignant Gliomas Following Standard Treatment |
Recruiting |
NCT02629757 |
Phase 3 |
β-elemene |
48 |
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-Controlled Study of AG-881 in Subjects With Residual or Recurrent Grade 2 Glioma With an IDH1 or IDH2 Mutation |
Active, not recruiting |
NCT04164901 |
Phase 3 |
Vorasidenib;Matching Placebo |
49 |
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial. |
Active, not recruiting |
NCT00626990 |
Phase 3 |
temozolomide |
50 |
A Phase III Clinical Trial Evaluating DCVax®-L, Autologous Dendritic Cells Pulsed With Tumor Lysate Antigen For The Treatment Of Glioblastoma Multiforme (GBM) |
Active, not recruiting |
NCT00045968 |
Phase 3 |
Dendritic cell immunotherapy |
|